Brandon S Sheffield Anna V Tinker Yaoqing Shen Harry Hwang Hector H Li-Chang Erin Pleasance Carolyn Ch'ng Amy Lum Julie Lorette Yarrow J McConnell Sophie Sun Steven J M Jones Allen M Gown David G Huntsman David F Schaeffer Andrew Churg Stephen Yip Janessa Laskin Marco A Marra
10.1371/journal.pone.0119689
PLoS One
2015 Mar 23;10(3):e0119689.
CC BY
https://pubmed.ncbi.nlm.nih.gov/25798586/
Cyclin-Dependent Kinase Inhibitor p16 / genetics Genes, Neurofibromatosis 2 Genome, Human High-Throughput Nucleotide Sequencing / methods Mesothelioma / genetics Peritoneal Neoplasms / genetics Protein Serine-Threonine Kinases / genetics Tumor Suppressor Proteins / genetics
Cyclin-Dependent Kinase Inhibitor p16 / genetics Genes, Neurofibromatosis 2 Genome, Human High-Throughput Nucleotide Sequencing / methods Mesothelioma / genetics Peritoneal Neoplasms / genetics Protein Serine-Threonine Kinases / genetics Tumor Suppressor Proteins / genetics Case Reports Research Support, Non-U.S. Gov't Adult Biomarkers, Tumor / genetics Female Genome-Wide Association Study Humans Middle Aged Precision Medicine Prognosis Biomarkers, Tumor Cyclin-Dependent Kinase Inhibitor p16 Tumor Suppressor Proteins LATS2 protein, human Protein Serine-Threonine Kinases
PMC4370594
25798586
Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing
2015